When COVID-19 vaccines rolled out, public health officials largely followed a simple logic: protect the most vulnerable first ...

AbbVie is to begin clinical development of an antibody designed to neutralise the SARS-CoV-2 coronavirus after licensing the therapy in from Harbour BioMed and Utrecht University. In a joint ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with 1 or more ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.

Jan 20 - Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining claims made in a U.S. broadcast that the inoculations have caused a ...

Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings reports from some major firms. The healthcare industry also had its fair share ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

What are COVID-19 protein-based vaccines? Protein-based vaccines use the specific parts of the virus that the immune system needs to recognise in order to develop an immune response. They do not ...

President Donald Trump signed an executive order Friday barring schools who still have coronavirus vaccine mandates from receiving federal funds. The order, according to a report from Breitbart ...